GSK just hit one of its main objectives for 2025 after getting FDA approval of anti-IL-5 antibody Nucala as a treatment for chronic obstructive pulmonary disease (COPD). Nucala (mepolizumab) has ...

Patients with primary biliary cholangitis (PBC) often say that severe pruritus (itching) is the most debilitating symptom of the autoimmune liver disease – and new data with a GSK candidate ...